Yale Bulletin and Calendar

November 15, 2002|Volume 31, Number 11



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


$11 million grant to fund center's work on autism

The Yale Child Study Center has received $11 million in grants -- and was designated the top research center among those awarded the funding -- to continue its internationally recognized research into autism and Asperger's syndrome.

A grant for $6 million results from Yale's designation as one of 10 centers for Collaborative Program of Excellence in Autism (CPEA). A second grant, which will total $5 million over five years, comes from the Studies to Advance Autism Research and Treatment (STAART) initiative sponsored by the National Institutes of Health.

The CPEA grant will fund longitudinal and follow-up studies of children with autism. It also will fund neuroimaging, research into the genetic basis of autism and a study of Asperger's syndrome, which, like autism, is partially characterized by an inability to engage appropriately with peers. The STAART-funded research focuses on the biomedical and behavioral aspects of autism.

"Because of the work we've done and continue to do, we can make a big difference in the lives of the autistic," says Dr. Fred Volkmar, professor of child psychiatry, pediatrics and psychology and principal investigator on the research project, of which Yale is the lead site. "In the past, people with autism tended to do very poorly, but with earlier detection more and more people with autism are leading active and productive lives."

Ami Klin, professor of child psychiatry and, with Volkmar, recipient of the STAART grant, says the grant will fund several areas of research, among them eye-tracking studies of social engagement; gaze-processing in young children with autism; roots of social communication with auditory preferences; behavioral and neural plasticity in face recognition; and fluvoxamine in children and adolescents with anxiety disorders.

Autism is now considered one of a group of illnesses collectively known as pervasive developmental disorders, affecting about 1 in 200 to 250 people.


T H I SW E E K ' SS T O R I E S

Yale revises early admissions policy

Koerner Center will serve as a 'focal point' . . .

$11 million grant to fund center's work on autism

Facility offers resources and a gathering place for graduate students

Former trade representative champions open markets

Graduate student Jun Saito wins a seat in Japanese Parliament

Yale artist tackles dirt and death in new projects

Fact feeds fiction in Yale alumnus' play 'Fighting Words'

Researchers create artificial 'light switch' to regulate genes

Display looks at 'Rocks, Gems and the Yale Seal'

Conference to focus on adolescents' alcohol, tobacco use

Yale staff consulted for soon-to-air PBS series . . .

Graduate student to discuss Lyndon Johnson biography

Honoring Yale's veterans

Yale Books in Brief


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Yale Scoreboard|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs Home|News Releases| E-Mail Us|Yale Home Page